J Gynecol Oncol.
2018 Nov;29(6):e88. 10.3802/jgo.2018.29.e88.
Clinical utility of CA-125 in the management of uterine carcinosarcoma
- Matsuo K
- Ross MS
- Yunokawa M
- Johnson MS
- Machida H
- Omatsu K
- Klobocista MM
- Im DD
- Satoh S
- Baba T
- Ikeda Y
- Bush SH
- Hasegawa K
- Blake EA
- Takekuma M
- Shida M
- Nishimura
- Adachi S
- Pejovic T
- Takeuchi S
- Yokoyama T
- Ueda Y
- Iwasaki K
- Miyake TM
- Yanai S
- Nagano T
- Takano T
- Shahzad MM
- Ueland FR
- Kelley JL
- Roman LD
- Affiliations
-
- 1Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, CA, USA. koji.matsuo@med.usc.edu
- 2Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Magee-Womens Hospital, University of Pittsburgh, Pittsburgh, PA, USA.
- 3Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
- 4Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Kentucky, Lexington, KY, USA.
- 5Department of Gynecology, Cancer Institute Hospital, Tokyo, Japan.
- 6Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY, USA.
- 7The Gynecologic Oncology Center, Mercy Medical Center, Baltimore, MD, USA.
- 8Department of Obstetrics and Gynecology, Tottori University, Tottori, Japan.
- 9Department of Obstetrics and Gynecology, Kyoto University, Kyoto, Japan.
- 10Department of Obstetrics and Gynecology, The University of Tokyo, Tokyo, Japan.
- 11Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Moffitt Cancer Center, University of South Florida, Tampa, FL, USA.
- 12Department of Obstetrics and Gynecology, Saitama Medical University International Medical Center, Saitama, Japan.
- 13Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Colorado, Denver, CO, USA.
- 14Department of Gynecology, Shizuoka Cancer Center, Shizuoka, Japan.
- 15Department of Obstetrics and Gynecology, Tokai University, Kanagawa, Japan.
- 16Department of Obstetrics and Gynecology, Tokushima University, Tokushima, Japan.
- 17Department of Obstetrics and Gynecology, Niigata University, Niigata, Japan.
- 18Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland, OR, USA.
- 19Department of Obstetrics and Gynecology, Iwate Medical University, Morioka, Japan.
- 20Department of Obstetrics and Gynecology, Osaka Rosai Hospital, Osaka, Japan.
- 21Department of Obstetrics and Gynecology, Osaka University, Osaka, Japan.
- 22Department of Obstetrics and Gynecology, Aichi Medical University, Aichi, Japan.
- 23Department of Obstetrics and Gynecology, Kawasaki Medical School, Okayama, Japan.
- 24Department of Obstetrics and Gynecology, Kurashiki Medical Center, Okayama, Japan.
- 25Department of Obstetrics and Gynecology, Kitano Hospital, Osaka, Japan.
- 26Department of Obstetrics and Gynecology, Tohoku University, Miyagi, Japan.
- KMID: 2431233
- DOI: http://doi.org/10.3802/jgo.2018.29.e88
Abstract
- No abstract available.
MeSH Terms
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- The Distribution of CA-125 Level Among the Patients Who Underwent Hysterectomy
- A clinical evaluation of CA 125 antigen values in patients of ovarian cancer
- Carcinosarcoma of Bladder: Report of a Case
- Predictive value of preoperative serum CA-125 levels in patients with uterine cancer: The Asian experience 2000 to 2012
- The efficacy of tumor markers SCC, CEA, and CA-125 in patients with cervical cancer
